The parathyroid hormone response to hypocalcemia was investigated in hemodialysis patients with osteomalacia and compared to those with osteitis fibrosa. Hypocalcemia was induced during hemodialysis by employing a dialysate devoid of calcium. Patients with osteomalacia had a blunted maximum amino terminal parathyroid hormone response (± SD) (0.39 ± 0.33 vs. 0.87 ± 0.53 ng/ml, P < 0.05) and maximum carboxy terminal parathyroid hormone response (± SD) (0.36 ± 0.20 vs. 0.84 ± 0.47, P < 0.02) to hypocalcemia. The decline in plasma calcium was greater in patients with osteomalacia at 90 (P < 0.05), 120 (P < 0.01), and 150 min (P < 0.01). In osteomalacia patients the surface density of histologically detectable trabecular bone aluminum correlated directly with the percent relative osteoid volume (P < 0.005) and inversely with the maximum amino terminal parathyroid hormone response to hypocalcemia (P < 0.025). These results suggest that hemodialysis patients with osteomalacia have diminished secretion of parathyroid hormone and a decreased ability to restore plasma calcium homeostasis during hypocalcemia.
CITATION STYLE
Andress, D., Felsenfeld, A. J., Voigts, A., & Llach, F. (1983). Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. Kidney International, 24(3), 364–370. https://doi.org/10.1038/ki.1983.168
Mendeley helps you to discover research relevant for your work.